Edap Tms (NASDAQ:EDAP) Earns Hold Rating from Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Edap Tms (NASDAQ:EDAP) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

Edap Tms Trading Down 0.8 %

Shares of NASDAQ:EDAP opened at $2.46 on Tuesday. Edap Tms has a 12-month low of $2.00 and a 12-month high of $8.50. The company has a market capitalization of $91.28 million, a PE ratio of -3.78 and a beta of 0.36. The business has a 50 day moving average of $2.40 and a two-hundred day moving average of $2.65. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Illumine Investment Management LLC acquired a new position in Edap Tms in the fourth quarter valued at approximately $50,000. Orion Capital Management LLC lifted its holdings in Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after acquiring an additional 6,600 shares during the period. Parkman Healthcare Partners LLC acquired a new position in Edap Tms in the third quarter valued at approximately $395,000. Millennium Management LLC raised its stake in shares of Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after buying an additional 33,558 shares during the period. Finally, Jane Street Group LLC raised its stake in shares of Edap Tms by 174.7% during the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after buying an additional 73,361 shares during the period. 62.74% of the stock is owned by institutional investors and hedge funds.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.